Mycobacterium bovis Bacille Calmette-Guérin as a Vaccine Vector for Global Infectious Disease Control.

Tuberculosis Research and Treatment
Kazuhiro Matsuo, Yasuhiro Yasutomi

Abstract

Mycobacterium bovis bacille Calmette-Guérin (BCG) is the only available vaccine for tuberculosis (TB). Although this vaccine is effective in controlling infantile TB, BCG-induced protective effects against pulmonary diseases in adults have not been clearly demonstrated. Recombinant BCG (rBCG) technology has been extensively applied to obtain more potent immunogenicity of this vaccine, and several candidate TB vaccines have currently reached human clinical trials. On the other hand, recent progress in the improvement of the BCG vector, such as the codon optimization strategy and combination with viral vector boost, allows us to utilize this bacterium in HIV vaccine development. In this paper, we review recent progress in rBCG-based vaccine studies that may have implications in the development of novel vaccines for controlling global infectious diseases in the near future.

References

Jun 1, 1977·Journal of General Microbiology·K TakeyaT Miyake
Apr 15, 1991·Annals of Internal Medicine·A S FauciG Pantaleo
Dec 1, 1990·Infection and Immunity·K MatsuoT Yamada
Dec 1, 1993·International Journal of Epidemiology·L C RodriguesJ G Wheeler
Mar 2, 1994·JAMA : the Journal of the American Medical Association·G A ColditzF Mosteller
Apr 3, 2001·Science·D Paydarfar, W J Schwartz
Feb 28, 2002·Annual Review of Immunology·Norman L LetvinDavid C Montefiori
Oct 18, 2002·Trends in Molecular Medicine·Rama Rao Amara, Harriet L Robinson
May 22, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Tetsuo KawashimaMasahiko Sugita
Jul 2, 2003·Nature Medicine·Andrew J McMichael, Tomas Hanke
Oct 28, 1961·Nature·I TAGAYAY SANO
Jun 24, 2004·The Journal of Experimental Medicine·Tetsuro MatanoYoshiyuki Nagai
Jan 22, 2005·Annual Review of Medicine·Norman L Letvin
Apr 7, 2005·Nature Medicine·Stefan H E Kaufmann, Andrew J McMichael
Jul 22, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Julie M RodaWilliam E Carson
Dec 13, 2005·Sexual Health·Miranda Z Smith, Stephen J Kent
Mar 21, 2007·Proceedings of the National Academy of Sciences of the United States of America·Roland BroschStewart T Cole
May 4, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Elizabeth A RamsburgJohn K Rose
Jun 23, 2007·Current Molecular Medicine·Rogelio Hernàndez-PandoYolanda Lopez-Vidal

❮ Previous
Next ❯

Citations

Oct 5, 2013·Immunobiology·Julia María Martínez GómezSylvie Alonso
Apr 2, 2013·Lancet·Bernd RechelMartin McKee
Jan 16, 2013·Clinical Biochemistry·Marwa M HussainHassan M E Azzazy
Mar 17, 2012·Bulletin of the World Health Organization·A MatteelliG B Migliori
May 15, 2013·Tuberculosis·Maryna SteynSamantha Pretorius
May 18, 2013·Journal of Medicinal Chemistry·Vadim MolodtsovKatsuhiko S Murakami
Jan 6, 2016·International Journal of Environmental Research and Public Health·Tao ZhangXiujun Li
Jun 12, 2012·Lancet·Jennifer HughesNathan Ford
Mar 27, 2012·Lancet·Mario RaviglioneAaron Motsoaledi
Mar 2, 2012·Archivos de bronconeumología·Dante R CulquiLuis A Suarez O
Oct 24, 2012·Cytometry. Part B, Clinical Cytometry·Frederic I Preffer
Jun 1, 2012·Osong Public Health and Research Perspectives·Jong Su ChoiJae-Ouk Kim
Feb 2, 2012·Lancet·Mario RaviglioneKarin Weyer
Feb 2, 2012·Lancet·Marcos A Espinal
Mar 19, 2014·Nanomedicine : Nanotechnology, Biology, and Medicine·Georgios PyrgiotakisPhilip Demokritou
Jan 28, 2012·The Lancet Infectious Diseases·Russell R KempkerHenry M Blumberg
Feb 7, 2012·Cell·Ajit LalvaniSaranya Sridhar
Aug 28, 2012·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Qingrui YouWei Kong
Feb 19, 2013·American Journal of Human Genetics·Audrey V GrantLaurent Abel
Jan 1, 2014·Molecular Therapy. Methods & Clinical Development·Narcís SaubiJoan Joseph
May 1, 2015·Clinical and Vaccine Immunology : CVI·Bryan E HartRichard Frothingham
Oct 5, 2012·Journal of Telemedicine and Telecare·Shama MohammedAamir J Khan
Nov 24, 2012·Journal of Clinical Microbiology·M Estée TörökSharon J Peacock
Aug 31, 2012·Journal of Clinical Microbiology·Zhiquan ShuDayong Gao
Feb 8, 2013·Journal of Clinical Microbiology·Nira R PollockAntonio Campos-Neto
Mar 6, 2013·Antimicrobial Agents and Chemotherapy·Sahal Al-HajojZiad Memish
Aug 24, 2012·Clinical and Vaccine Immunology : CVI·Nancy D MarínLuis F García
Aug 29, 2012·Antimicrobial Agents and Chemotherapy·Benoit LechartierStewart T Cole
Oct 27, 2012·Tuberculosis and Respiratory Diseases·Bo Young LeeYeon-Mok Oh

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.